Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain

Pain

Volumn 73, Issue 3, 1997, Pages 369-375

  Lorenz, Jürgen ^a   Beck, Helge ^a   Bromm, Burkhart ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Chronic non malignant pain; Cognitive function; Laser evoked potentials; Morphine; P300; PAin measuremen

Indexed keywords

MORPHINE;

ADULT; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CROHN DISEASE; ELECTROENCEPHALOGRAM; EVOKED AUDITORY RESPONSE; HUMAN; LOW BACK PAIN; MOOD; NEUROPATHY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION;

ADULT; AFFECT; ANALGESICS, OPIOID; CHRONIC DISEASE; COGNITION; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASERS; MIDDLE AGED; MORPHINE; PAIN; PAIN MEASUREMENT; REACTION TIME; TIME FACTORS;

EID: 0031436682     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00123-1     Document Type: Article

References (29)

1. Arendt-Nielsen, L. and Gotliebsen, K., Segmental inhibition of laser-evoked brain potentials by ipsi- and contralaterally applied cold pressor pain, Eur. J. Appl. Physiol., 64 (1992) 56-61.
2. Birbaumer, N., Flor, H., Lutzenberger, W. and Elbert, T., The corticalization of chronic pain. In: B. Bromm and J. Desmedt (Eds.), Pain and the Brain. From Nociception to Cognition, Raven Press, New York, 1995, pp. 331-343.
3. Bromm, B. and Treede, R.-D., Laser evoked cerebral potentials in the assessment of cutaneous pain sensitivity in normal subjects and patients, Rév. Neurol., 147 (1991) 625-643.
4. Bruera, E., Macmillan, K., Hanson, J.A. and MacDonald, R.N., The cognitive effects of the administration of narcotic analgesics in patients with cancer pain, Pain, 39 (1989) 13-16.
5. Chen, A.C.N. and Treede, R.-D., The McGill Pain Questionnaire in the assessment of phasic and tonic experimental pain: behavioral evaluation of the 'pain inhibiting pain' effect, Pain, 22 (1985) 67-79.
6. Chen, A.C.N., Treede, R.-D. and Bromm, B., Modulation of pain evoked cerebral potential by concurrent subacute pain. In: B. Bromm (Ed.), Pain Measurement in Man. Neurophysiological Correlates of Pain, Elsevier, Amsterdam, 1984, pp. 301-310.
7. Dubner, R. and Ruda, M.A., Activity-dependent neuronal plasticity following tissue injury and inflammation, Trends Neurosci., 15 (1992) 96-103.
8. Easterbrook, J.A., The effect of emotion on cue utilization and the organization of behavior, Psychol. Rev., 66 (3) (1959) 183-201.
9. Ecclestone, C., The attentional control of pain: methodological and theoretical concerns, Pain, 63 (1995) 3-10.
10. Engelhardt, W., Friess, K., Hartung, E., Sold, M. and Dierks, T., EEG and auditory evoked potential P300 compared with psychometric tests in assessing vigilance after benzodiazepine sedation and antagonism, Br. J. Anaesth., 69 (1992) 75-80.
11. Goodin, D.S., Clinical utility of long-latency 'cognitive' event-related components (P3): the pros, Electroenceph. clin. Neurophysiol., 76 (1990) 2-5.
12. Karniski, W. and Blair, R.C., Topographical and temporal stability of the P300, Electroenceph. clin. Neurophysiol., 72 (1989) 373-383.
13. Le Bars, D., Dickenson, A.H. and Besson, J.M., Diffuse noxious inhibitory controls (DNIC). I. Effect on dorsal horn convergent neurons, Pain, 6 (1979) 283-304.
14. Lorenz, J. and Bromm, B., Event related potential correlates of interference between cognitive performance and tonic experimental pain, Psychophysiology, 34 (1997) 436-445.
15. Lorenz, J., Beck, H. and Bromm, B., Differential changes of laser evoked potentials, late auditory evoked potentials and P300 under morphine in chronic pain patients, Electroenceph. clin. Neurophysiol., (1997) in press.
16. Lorenz, J., Baumgärtner, U., Zander, A.R. and Bromm, B., Differenzierung von schmerz- und morphinbedingter Beeinträchtigung kognitiver Leistungen und subjektiver Befindlichkeit bei Knochenmarktransplantationspatienten, Der Schmerz, 10 (1996) 80-88.
17. Pfefferbaum, A., Ford, J.M. and Kraemer, H.C., Clinical utility of long-latency 'cognitive' event-related components (P3): the cons, Electroenceph. clin. Neurophysiol., 76 (1990) 6-12.
18. Polich, J., P300 in clinical applications: meaning, method, and measurement. In: E. Niedermeyer and F.L. Da Silva (Eds.), Electroencephalograpy: Basic Principles, Clinical Applications, and Related Fields, 3rd edn., Williams and Wilkins, Baltimore, MD, 1993, pp. 1005-1018.
19. Portenoy, R.K., Chronic opioid therapy in non-malignant pain, J. Pain Symptom Manage., 5 (1) (1990) 46-62.
20. Riemenschneider, S., Verkehrsrechtliche Aspekte medikamentöser Schmerztherapie, Der Schmerz, 11 (1997) 158-164.
21. Saletu, B., Grünberger, J., Linzmayer, L. and Anderer, P., Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry, Pharmacopsychiatry, 20 (1987) 12-27.
22. Scharein, E. and Bromm, B., Comparative evaluation of analgesic efficacy of drugs. In: B. Bromm and J. Desmedt (Eds.), Pain and the Brain. From Nociception to Cognition, Raven Press, New York, 1995, pp. 473-500.
23. Vainio, A., Olliia, J., Matikainen, E., Rosenberg, P. and Kalso, E., Driving ability in cancer patients receiving long-term morphine analgesia, Lancet, 346 (1995) 667-670.
24. Velasco, M., Velasco, F., Castaneda, R. and Lee, M., Effect of fentanyl and naloxone on the P300 auditory potential, Neuropharmacology, 23 (8) (1984) 931-938.
25. Ventafridda, V., Tamburini, M., Caraceni, A., De Conno, F. and Naldi, F., A validation study of the WHO method for cancer pain relief, Cancer, 59 (1987) 850-856.
26. Villanueva, L., Bouhassira, D. and Le Bars, D., The medullary subnucleus reticularis dorsalis (SRD) as a key link in both the transmission and modulation of pain signals, Pain, 67 (1996) 231-240.
27. Zaslansky, R., Sprecher, E., Tenke, C.E., Hemli, J.A. and Yarnitzky, D., The P300 in pain evoked potentials, Pain, 66 (1996) 39-49.
28. Zenz, M., Strumpf, M., Tryba, M., Röhrs, E. and Steffmann, B., Retardiertes Morphin zur Langzeittherapie schwerer Tumorschmerzen, Dtsch. Med. Wschr., 114 (1989) 43-47.
29. Zerssen, D., Koeller, D.M. and Rey, E.R., Die Befindlichkeitsskala (B-S) -ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen, Arzneim. Forsch., 20 (1979) 915-918.